Joshua M L Casan

8PUBLICATIONS
27CO-AUTHORS
Molecular targetsHaematological tumoursInstruments and techniquesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 09, 2026
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

|May 14, 2026
On the RAdR in relapsed T-cell lymphoma.

|Feb 17, 2026
Refinement of the classification of DDX41 variants through analysis of aggregated clinical datasets.

Ing Soo Tiong, Sally Hunter, Yamuna Kankanige

|Nov 26, 2025
Personalized Immunotherapy for T Cell Lymphomas: From Immune Escape to Precision Therapeutics.

Joshua M L Casan, Xiao Jing Ong, Carrie van der Weyden

|Dec 18, 2024
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision.

Carolyn Shembrey, Ray Yang, Joshua Casan

|Jul 01, 2024
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing.

Wenxin Hu, Amit Kumar, Syed Faraz Ahmed

Pageof 2

Frequent Collaborators

3 joint publications

Paul G Ekert

3 joint publications

Mohamed Fareh

2 joint publications

Carolyn Shembrey

2 joint publications

John F Seymour